Immunome (IMNM) Net Margin (2023 - 2025)
Immunome (IMNM) posted Net Margin of 1751.01% for Q2 2025, down 14.11% on a QoQ basis from 1534.52% in Q1 2025, and up 189650.0% year-over-year from N/an in Q2 2024.
Immunome (IMNM) Net Margin (2023 - 2025) Analysis & Trends
Immunome's Net Margin history runs 3 years deep, the most recent figure standing at 1751.01% for Q2 2025.
- Quarterly Net Margin rose 189650.0% year-over-year to 1751.01% in Q2 2025, while the trailing twelve-month figure through Mar 2026 was 12193.18% (down 917135.0% YoY) and the FY2025 annual result came in at 5831.74%, down 126897.0% from the prior year.
- Net Margin was 1751.01% for Q2 2025 at Immunome, down from 1534.52% in the prior quarter.
- Across five years, Net Margin topped out at 121.88% in Q3 2023 and bottomed at 12866.76% in Q1 2024.
- A 3-year average of 2994.52% and a median of 2086.09% in 2023 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2024 — Net Margin tumbled 1267341 bps — and 2025, when it jumped 1133225 bps.
- Immunome's Net Margin stood at 2421.17% in 2023, then slipped by 26 bps to 3041.23% in 2024, then soared by 42 bps to 1751.01% in 2025.
- Business Quant data shows IMNM's Net Margin at 1751.01% in Q2 2025, 1534.52% in Q1 2025, and 3041.23% in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Immunome | 2.49 Bn | 1.91 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -1,751.01% |
| Mar 31, 2025 | -1,534.52% |
| Dec 31, 2024 | -3,041.23% |
| Sep 30, 2024 | -3,990.76% |
| Jun 30, 2024 | -3,647.50% |
| Mar 31, 2024 | -12,866.76% |
| Dec 31, 2023 | -2,421.17% |
| Sep 30, 2023 | -121.88% |
| Jun 30, 2023 | -377.03% |
| Mar 31, 2023 | -193.36% |